Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

George Dickson

Showing results (101-110 of 107) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|April 21, 2021
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathwaysVictoria Gudiño, Sebastian Öther-Gee Pohl, Caroline V Billard, et al.
The Lancet. Neurology|August 29, 2009
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyMaria Kinali, Virginia Arechavala-Gomeza, Lucy Feng, et al.
Human Gene Therapy|December 22, 2004
Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophyNorma B Romero, Serge Braun, Olivier Benveniste, et al.
Gene Therapy|February 2, 2022
Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMD<sup>mdx</sup> rat modelAudrey Bourdon, Virginie François, Liwen Zhang, et al.
Nucleic Acids Research|April 3, 2012
Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleasesFayza Daboussi, Mikhail Zaslavskiy, Laurent Poirot, et al.
Nature Communications|July 26, 2017
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophyCaroline Le Guiner, Laurent Servais, Marie Montus, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Pageof 11

Showing results (101-110 of 107) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 107 results.
Nature Communications|April 21, 2021
RAC1B modulates intestinal tumourigenesis via modulation of WNT and EGFR signalling pathwaysVictoria Gudiño, Sebastian Öther-Gee Pohl, Caroline V Billard, et al.
The Lancet. Neurology|August 29, 2009
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept studyMaria Kinali, Virginia Arechavala-Gomeza, Lucy Feng, et al.
Human Gene Therapy|December 22, 2004
Phase I study of dystrophin plasmid-based gene therapy in Duchenne/Becker muscular dystrophyNorma B Romero, Serge Braun, Olivier Benveniste, et al.
Gene Therapy|February 2, 2022
Evaluation of the dystrophin carboxy-terminal domain for micro-dystrophin gene therapy in cardiac and skeletal muscles in the DMD<sup>mdx</sup> rat modelAudrey Bourdon, Virginie François, Liwen Zhang, et al.
Nucleic Acids Research|April 3, 2012
Chromosomal context and epigenetic mechanisms control the efficacy of genome editing by rare-cutting designer endonucleasesFayza Daboussi, Mikhail Zaslavskiy, Laurent Poirot, et al.
Nature Communications|July 26, 2017
Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophyCaroline Le Guiner, Laurent Servais, Marie Montus, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Pageof 11